1. Sarode G, Maniyar N, Sarode SC, Jafer M, Patil S, Awan KH. Epidemiologic aspects of oral cancer. Dis Mon. 2020;66:100988.

https://doi.org/10.1016/j.disamonth.2020.100988

PMid:32605720 

2. Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin. 2002;52:195-215.

https://doi.org/10.3322/canjclin.52.4.195

PMid:12139232 

3. López-López J, Omaña-Cepeda C, Jané-Salas E. Precáncer y cáncer bucal. Med Clin (Barc). 2015;145:404-8.

https://doi.org/10.1016/j.medcli.2014.11.014

PMid:25638423 

4. Zanoni DK, Montero PH, Migliacci JC, Shah JP, Wong RJ, Ganly I, Patel SG. Survival outcomes after treatment of cancer of the oral cavity (1985-2015). Oral Oncol. 2019;90:115-21.

https://doi.org/10.1016/j.oraloncology.2019.02.001

PMid:30846169 PMCid:PMC6417804

5. Chiamulera MMA, Zancan CB, Remor AP, Cordeiro MF, Gleber-Netto FO, Baptistella AR. Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis. BMC Cancer. 2021;21:205.

https://doi.org/10.1186/s12885-021-07932-3

PMid:33639868 PMCid:PMC7912500

6. Dionne KR, Warnakulasuriya S, Zain RB, Cheong SC. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Cancer. 2015;136:503-15.

PMid:24482244

7. Ferrari E, Pezzi ME, Cassi D, Pertinhez TA, Spisni A, Meleti M. Salivary cytokines as biomarkers for oral squamous cell carcinoma: A systematic review. Int J Mol Sci. 2021;22:6795.

https://doi.org/10.3390/ijms22136795

PMid:34202728 PMCid:PMC8267678

8. Zielińska K, Karczmarek-Borowska B, Kwaśniak K, Czarnik-Kwaśniak J, Ludwin A, Lewandowski B, et al. Salivary IL-17A, IL-17F, and TNF-α are associated with disease advancement in patients with oral and oropharyngeal cancer. J Immunol Res. 2020 ;2020:3928504.

https://doi.org/10.1155/2020/3928504

PMid:32855976 PMCid:PMC7443019

9. Pérez-Sayáns M, Somoza-Martín JM, Barros-Angueira F, Reboiras-López MD, Gándara Rey JM, García-García A. Genetic and molecular alterations associated with oral squamous cell cancer (Review). Oncol Rep. 2009;22:1277-82.

https://doi.org/10.3892/or_00000565

PMid:19885577

10. Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014; 2014:149185.

https://doi.org/10.1155/2014/149185

PMid:24901008 PMCid:PMC4036716

11. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336-41.

https://doi.org/10.1016/j.ijsu.2010.02.007

PMid:20171303 

12. Korostoff A, Reder L, Masood R, Sinha UK. The role of salivary cytokine biomarkers in tongue cancer invasion and mortality. Oral Oncol. 2011;47:282-7.

https://doi.org/10.1016/j.oraloncology.2011.02.006

PMid:21397550 

13. Lisa Cheng Y-S, Jordan L, Gorugantula LM, Schneiderman E, Chen H-S, Rees T. Salivary interleukin-6 and -8 in patients with oral cancer and patients with chronic oral inflammatory diseases. J Periodontol. 2014;85:956-65.

https://doi.org/10.1902/jop.2013.130320

PMid:24147842 

14. Krishnan R, Thayalan DK, Padmanaban R, Ramadas R, Annasamy RK, Anandan N. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease. Asian Pac J Cancer Prev. 2014;15:7141-8.

https://doi.org/10.7314/APJCP.2014.15.17.7141

PMid:25227804 

15. Panneer Selvam N, Sadaksharam J. Salivary interleukin-6 in the detection of oral cancer and precancer: Salivary IL-6 in oral cancer and precancer. Asia Pac J Clin Oncol. 2015;11:236-41.

https://doi.org/10.1111/ajco.12330

PMid:25560781 

16. Khyani IAM, Qureshi MA, Mirza T, Farooq MU. Detection of interleukins-6 and 8 in saliva as potential biomarkers of oral pre-malignant lesion and oral carcinoma: A breakthrough in salivary diagnostics in Pakistan. Pak J Pharm Sci. 2017;30:817-23.

PMid:28653927

17. Ameena M, Rathy R. Evaluation of tumor necrosis factor: Alpha in the saliva of oral cancer, leukoplakia, and healthy controls - A comparative study. J Int Oral Health. 2019;11:92.

https://doi.org/10.4103/jioh.jioh_202_18

PMid:

18. St John MA, Li Y, Zhou X, Denny P, Ho C-M, Montemagno C, Shi W, Qi F, Wu B, Sinha U, Jordan R, Wolinsky L, Park NH, Liu H, Abemayor E, Wong DT. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:929-35.

https://doi.org/10.1001/archotol.130.8.929

PMid:15313862 

19. Rhodus NL, Ho V, Miller CS, Myers S, Ondrey F. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev. 2005;29:42-5.

https://doi.org/10.1016/j.cdp.2004.10.003

PMid:15734216 

20. Katakura A, Kamiyama I, Takano N, Shibahara T, Muramatsu T, Ishihara K, Takagi R, Shouno T. Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll. 2007;48:199-203.

https://doi.org/10.2209/tdcpublication.48.199

PMid:18360107 

21. SahebJamee M, Eslami M, AtarbashiMoghadam F, Sarafnejad A. Salivary concentration of TNFalpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2008;13:E292-5.

PMid:18449112

22. Al Talabani NG, Gaphor SM, Hamad A-WR. Serum and salivary levels of proinflammatory cytokines as potential biomarkers in the diagnosis of oral squamous cell carcinoma. Journal of baghdad college of dentistry. 2009.

PMid:

23. Brinkmann O, Kastratovic DA, Dimitrijevic MV, Konstantinovic VS, Jelovac DB, Antic J, et al. Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian population. Oral Oncol. 2011;47:51-5.

https://doi.org/10.1016/j.oraloncology.2010.10.009

PMid:21109482 PMCid:PMC3032819

24. Elashoff D, Zhou H, Reiss J, Wang J, Xiao H, Henson B, Hu S, Arellano M, Sinha U, Le A, Messadi D, Wang M, Nabili V, Lingen M, Morris D, Randolph T, Feng Z, Akin D, Kastratovic DA, Chia D, Abemayor E, Wong DT. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev. 2012;21:664-72.

https://doi.org/10.1158/1055-9965.EPI-11-1093

PMid:22301830 PMCid:PMC3319329

25. Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A, et al. Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Med Oral Patol Oral Cir Bucal. 2012;17:e10-5.

https://doi.org/10.4317/medoral.17323

PMid:21743397 PMCid:PMC3448188

26. Punyani SR, Sathawane RS. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma. Clin Oral Investig. 2013;17:517-24.

https://doi.org/10.1007/s00784-012-0723-3

PMid:22526890 

27. Juretić M, Cerović R, Belušić-Gobić M, Brekalo Pršo I, Kqiku L, Špalj S, Pezelj-Ribarić S. Salivary levels of TNF-α and IL-6 in patients with oral premalignant and malignant lesions. Folia Biol (Praha). 2013;59:99-102.

PMid:23746176

28. Rajkumar K, Nandhini G, Ramya R, Rajashree P, Kumar AR, Anandan SN. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:309-19.

https://doi.org/10.1016/j.oooo.2014.04.008

PMid:24950604 

29. Radulescu R, Totan A, Calenic B, Totan C, Greabu M. Biomarkers of oxidative stress, proliferation, inflammation and invasivity in saliva from oral cancer patients. J Anal Oncol. 2015;4:52-7.

https://doi.org/10.6000/1927-7229.2015.04.01.9

PMid:

30. Gleber-Netto FO, Yakob M, Li F, Feng Z, Dai J, Kao HK, Chang YL, Chang KP, Wong DT. Salivary biomarkers for detection of oral squamous cell carcinoma in a Taiwanese population. Clin Cancer Res. 2016;22:3340-7.

https://doi.org/10.1158/1078-0432.CCR-15-1761

PMid:26847061 PMCid:PMC4930722

31. Polz-Dacewicz M, Strycharz-Dudziak M, Dworzański J, Stec A, Kocot J. Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections. Infect Agent Cancer. 2016;11:45.

https://doi.org/10.1186/s13027-016-0093-6

PMid:27547238 PMCid:PMC4992298

32. Dineshkumar T, Balakuntla Krishnamurthy A, Annasamy R, Padmanaban R, Ramadas R, Krishnan R. Salivary and serum interleukin-6 levels in oral premalignant disorders and squamous cell carcinoma: Diagnostic value and clinicopathologic correlations. Asian Pac J Cancer Prev. 2016;17:4899-906.

PMid:28032493

33. Deepthi G, Nandan SRK, Kulkarni PG. Salivary Tumour necrosis factor-α as a biomarker in oral leukoplakia and Oral Squamous Cell Carcinoma. Asian Pac J Cancer Prev. 2019;20:2087-93.

https://doi.org/10.31557/APJCP.2019.20.7.2087

PMid:31350970 PMCid:PMC6745219

34. Singh P, Verma JK, Singh JK. Validation of salivary markers, IL-1β, IL-8 and Lgals3bp for detection of oral squamous cell carcinoma in an Indian population. Sci Rep. 2020;10:7365.

https://doi.org/10.1038/s41598-020-64494-3

PMid:32355279 PMCid:PMC7192911